期刊论文详细信息
BMC Medical Genetics
Polymorphisms in GCKR, SLC17A1 and SLC22A12 were associated with phenotype gout in Han Chinese males: a case–control study
Chang-Gui Li1  Yong-Yong Shi2  Xiao-Min Wang1  Zu-Jia Wen2  Jian-Hua Chen2  Zhi-Qiang Li2  Jia-Wei Shen2  Zhi-Jian Song2  Can Wang1  Lin Han1  Ling-Ling Cui1  Zhao-Wei Zhou1 
[1]Shandong Provincial Key Laboratory of Metabolic Disease, The Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao 266003, China
[2]Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, China
关键词: SLC22A12;    SLC17A1;    GCKR;    SNPs;    Gout;   
Others  :  1223156
DOI  :  10.1186/s12881-015-0208-8
 received in 2015-01-15, accepted in 2015-07-30,  发布年份 2015
PDF
【 摘 要 】

Background

Gout is a common arthritic disease resulting from elevated serum uric acid (SUA) level. A large meta-analysis including 28,141 individuals identified nine single nucleotide polymorphisms (SNPs) associated with altered SUA level in a Caucasian population. However, raised SUA level alone is not sufficient for the development of gout arthritis and most of these SNPs have not been studied in a Han Chinese population. Here, we performed a case–control association analysis to investigate the relationship between these SUA correlated SNPs and gout arthritis in Han Chinese.

Methods

A total of 622 ascertained gout p9atients and 917 healthy controls were genotyped. Genome-wide significant SNPs, rs12129861, rs780094, rs734553, rs742132, rs1183201, rs12356193, rs17300741 and rs505802 in the previous SUA study, were selected for our analysis.

Results

No deviation from the Hardy–Weinberg equilibrium was observed either in the case or control cohorts (corrected p > 0.05). Three SNPs, rs780094 (located in GCKR, corrected p = 1.78E −4 , OR = 0.723), rs1183201 (located in SLC17A1, corrected p = 1.39E −7 , OR = 0.572) and rs505802 (located in SLC22A12, corrected p = 0.007, OR = 0.747), were significantly associated with gout on allelic level independent of potential cofounding traits. While the remaining SNPs were not replicated. We also found significant associations of uric acid concentrations with these three SNPs (rs780094 in GCKR, corrected p = 3.94E −5 ; rs1183201 in SLC17A1, corrected p = 0.005; rs505802 in SLC22A12, corrected p = 0.003) and of triglycerides with rs780094 (located in GCKR, corrected p = 2.96E −4 ). Unfortunately, SNP-SNP interactions for these three significant SNPs were not detected (rs780094 vs rs1183201, p = 0.402; rs780094 vs rs505802, p = 0.434; rs1183201 vs rs505802, p = 0.143).

Conclusions

Three SUA correlated SNPs in Caucasian population, rs780094 in GCKR, rs1183201 in SLC17A1 and rs505802 in SLC22A12 were confirmed to be associated with gout arthritis and uric acid concentrations in Han Chinese males. Considering genetic differences among populations and complicated pathogenesis of gout arthritis, more validating tests in independent populations and relevant functional experiments are suggested in future.

【 授权许可】

   
2015 Zhou et al.

【 预 览 】
附件列表
Files Size Format View
20150901021726583.pdf 768KB PDF download
Fig. 1. 54KB Image download
【 图 表 】

Fig. 1.

【 参考文献 】
  • [1]Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther. 2010; 12:223. BioMed Central Full Text
  • [2]Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis. 2008; 67:960-966.
  • [3]Chuang SY, Lee SC, Hsieh YT, Pan WH. Trends in hyperuricemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993–1996 to 2005–2008. Asia Pac J Clin Nutr. 2011; 20:301-308.
  • [4]Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z, Chen X, Xu F, Wang F, Sun R et al.. Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol. 2008; 35:1859-1864.
  • [5]Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011; 63:3136-3141.
  • [6]Brook RA, Kleinman NL, Patel PA, Melkonian AK, Brizee TJ, Smeeding JE, Joseph-Ridge N. The economic burden of gout on an employed population. Curr Med Res Opin. 2006; 22:1381-1389.
  • [7]Wilk JB, Djousse L, Borecki I, Atwood LD, Hunt SC, Rich SS, Eckfeldt JH, Arnett DK, Rao DC, Myers RH. Segregation analysis of serum uric acid in the NHLBI Family Heart Study. Hum Genet. 2000; 106:355-359.
  • [8]Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, Boerwinkle E, Levy D, Hofman A, Astor BC et al.. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008; 372:1953-1961.
  • [9]Doring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, Fischer G, Henke K, Klopp N, Kronenberg F et al.. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet. 2008; 40:430-436.
  • [10]Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, Knott SA, Kolcic I, Polasek O, Graessler J et al.. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008; 40:437-442.
  • [11]Yang B, Mo Z, Wu C, Yang H, Yang X, He Y, Gui L, Zhou L, Guo H, Zhang X et al.. A genome-wide association study identifies common variants influencing serum uric acid concentrations in a Chinese population. BMC Med Genet. 2014; 7:10.
  • [12]Yang Q, Kottgen A, Dehghan A, Smith AV, Glazer NL, Chen MH, Chasman DI, Aspelund T, Eiriksdottir G, Harris TB et al.. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet. 2010; 3:523-530.
  • [13]Kamatani Y, Matsuda K, Okada Y, Kubo M, Hosono N, Daigo Y, Nakamura Y, Kamatani N. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet. 2010; 42:210-215.
  • [14]Okada Y, Sim X, Go MJ, Wu JY, Gu D, Takeuchi F, Takahashi A, Maeda S, Tsunoda T, Chen P et al.. Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations. Nat Genet. 2012; 44:904-909.
  • [15]Sull JW, Yang SJ, Kim S, Jee SH. The ABCG2 Polymorphism rs2725220 Is Associated with Hyperuricemia in the Korean Population. Genome Inform. 2014; 12:231-235.
  • [16]Voruganti VS, Kent JW, Debnath S, Cole SA, Haack K, Goring HH, Carless MA, Curran JE, Johnson MP, Almasy L et al.. Genome-wide association analysis confirms and extends the association of SLC2A9 with serum uric acid levels to Mexican Americans. Front Genet. 2013; 4:279.
  • [17]Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, Mangino M, Albrecht E, Wallace C, Farrall M et al.. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 2009; 5: Article ID e1000504
  • [18]Kottgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, Pistis G, Ruggiero D, O'Seaghdha CM, Haller T et al.. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013; 45:145-154.
  • [19]van der Harst P, Bakker SJ, de Boer RA, Wolffenbuttel BH, Johnson T, Caulfield MJ, Navis G. Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. Hum Mol Genet. 2010; 19:387-395.
  • [20]Stark K, Reinhard W, Grassl M, Erdmann J, Schunkert H, Illig T, Hengstenberg C. Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease. PLoS One. 2009; 4:e7729.
  • [21]Sakiyama M, Matsuo H, Shimizu S, Chiba T, Nakayama A, Takada Y, Nakamura T, Takada T, Morita E, Naito M et al.. Common variant of leucine-rich repeat-containing 16A (LRRC16A) gene is associated with gout susceptibility. Hum Cell. 2014; 27:1-4.
  • [22]Urano W, Taniguchi A, Inoue E, Sekita C, Ichikawa N, Koseki Y, Kamatani N, Yamanaka H. Effect of genetic polymorphisms on development of gout. J Rheumatol. 2013; 40:1374-1378.
  • [23]Wang J, Liu S, Wang B, Miao Z, Han L, Chu N, Zhang K, Meng D, Li C, Ma X. Association between gout and polymorphisms in GCKR in male Han Chinese. Hum Genet. 2012; 131:1261-1265.
  • [24]Phipps-Green AJ, Merriman ME, Topless R, Altaf S, Montgomery GW, Franklin C et al.: Twenty-eight loci that influence serum urate levels: analysis of association with gout. Annals of the rheumatic diseases 2014 Sep 3.
  • [25]Hollis-Moffatt JE, Phipps-Green AJ, Chapman B, Jones GT, van Rij A, Gow PJ, Harrison AA, Highton J, Jones PB, Montgomery GW et al.. The renal urate transporter SLC17A1 locus: confirmation of association with gout. Arthritis Res Ther. 2012; 14:R92. BioMed Central Full Text
  • [26]Guan M, Zhou D, Ma W, Chen Y, Zhang J, Zou H. Association of an intronic SNP of SLC2A9 gene with serum uric acid levels in the Chinese male Han population by high-resolution melting method. Clin Rheumatol. 2011; 30:29-35.
  • [27]Tu HP, Chen CJ, Tovosia S, Ko AM, Lee CH, Ou TT, Lin GT, Chang SJ, Chiang SL, Chiang HC et al.. Associations of a non-synonymous variant in SLC2A9 with gouty arthritis and uric acid levels in Han Chinese subjects and Solomon Islanders. Ann Rheum Dis. 2010; 69:887-890.
  • [28]Dong Z, Guo S, Yang Y, Wu J, Guan M, Zou H, Jin L, Wang J. Association between ABCG2 Q141K polymorphism and gout risk affected by ethnicity and gender: a systematic review and meta-analysis. International journal of rheumatic diseases. 2015 May;18(4):382–91.
  • [29]Li FG, Chu Y, Meng DM, Tong YW. [Association of ABCG2 gene C421A polymorphism and susceptibility of primary gout in Han Chinese males]. Zhonghua yi xue yi chuan xue za zhi. 2011; 28:683-685.
  • [30]Wang B, Miao Z, Liu S, Wang J, Zhou S, Han L, Meng D, Wang Y, Li C, Ma X. Genetic analysis of ABCG2 gene C421A polymorphism with gout disease in Chinese Han male population. Hum Gen. 2010; 127:245-246.
  • [31]Zhou D, Liu Y, Zhang X, Gu X, Wang H, Luo X, Zhang J, Zou H, Guan M. Functional polymorphisms of the ABCG2 gene are associated with gout disease in the Chinese Han male population. Int J Mol Sci. 2014; 15:9149-9159.
  • [32]Li C, Han L, Levin AM, Song H, Yan S, Wang Y, Wang Y, Meng D, Lv S, Ji Y et al.. Multiple single nucleotide polymorphisms in the human urate transporter 1 (hURAT1) gene are associated with hyperuricaemia in Han Chinese. J Med Genet. 2010; 47:204-210.
  • [33]Li C, Yu Q, Han L, Wang C, Chu N, Liu S. The hURAT1 rs559946 polymorphism and the incidence of gout in Han Chinese men. Scand J Rheumatol. 2014; 43:35-42.
  • [34]Tu HP, Chen CJ, Lee CH, Tovosia S, Ko AM, Wang SJ, Ou TT, Lin GT, Chiang SL, Chiang HC et al.. The SLC22A12 gene is associated with gout in Han Chinese and Solomon Islanders. Ann Rheum Dis. 2010; 69:1252-1254.
  • [35]Wan W, Xu X, Zhao DB, Pang YF, Wang YX. Polymorphisms of uric transporter proteins in the pathogenesis of gout in a Chinese Han population. Genet Mol Res. 2015; 14:2546-2550.
  • [36]Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977; 20:895-900.
  • [37]Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, He L, Shi Y. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res. 2009; 19:519-523.
  • [38]Dupont WD, Plummer WD. Power and sample size calculations for studies involving linear regression. Control Clin Trials. 1998; 19:589-601.
  • [39]Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008; 359:1811-1821.
  • [40]Orho-Melander M, Melander O, Guiducci C, Perez-Martinez P, Corella D, Roos C, Tewhey R, Rieder MJ, Hall J, Abecasis G et al.. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes. 2008; 57:3112-3121.
  • [41]Tang L, Ye H, Hong Q, Wang L, Wang Q, Wang H, Xu L, Bu S, Zhang L, Cheng J et al.. Elevated CpG island methylation of GCK gene predicts the risk of type 2 diabetes in Chinese males. Gene. 2014; 547:329-333.
  • [42]Mit LU, Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ et al.. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007; 316:1331-1336.
  • [43]Qi Q, Wu Y, Li H, Loos RJ, Hu FB, Sun L, Lu L, Pan A, Liu C, Wu H et al.. Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population. Diabetologia. 2009; 52:834-843.
  • [44]Sparso T, Andersen G, Nielsen T, Burgdorf KS, Gjesing AP, Nielsen AL, Albrechtsen A, Rasmussen SS, Jorgensen T, Borch-Johnsen K et al.. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetologia. 2008; 51:70-75.
  • [45]Vaxillaire M, Cavalcanti-Proenca C, Dechaume A, Tichet J, Marre M, Balkau B, Froguel P, Group DS. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes. 2008; 57:2253-2257.
  • [46]Tam CH, Ma RC, So WY, Wang Y, Lam VK, Germer S, Martin M, Chan JC, Ng MC. Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents. Diabetes. 2009; 58:765-769.
  • [47]Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T et al.. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature. 2002; 417:447-452.
  • [48]Karns R, Zhang G, Sun G, Rao Indugula S, Cheng H, Havas-Augustin D, Novokmet N, Rudan D, Durakovic Z, Missoni S et al.. Genome-wide association of serum uric acid concentration: replication of sequence variants in an island population of the Adriatic coast of Croatia. Ann Hum Genet. 2012; 76:121-127.
  • [49]Tin A, Woodward OM, Kao WH, Liu CT, Lu X, Nalls MA, Shriner D, Semmo M, Akylbekova EL, Wyatt SB et al.. Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. Hum Mol Genet. 2011; 20:4056-4068.
  • [50]Flynn TJ, Phipps-Green A, Hollis-Moffatt JE, Merriman ME, Topless R, Montgomery G, Chapman B, Stamp LK, Dalbeth N, Merriman TR. Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case–control sample sets reveals multiple ancestral-specific effects. Arthritis Res Ther. 2013; 15:R220. BioMed Central Full Text
  • [51]Iharada M, Miyaji T, Fujimoto T, Hiasa M, Anzai N, Omote H, Moriyama Y. Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl(−)-dependent urate exporter. J Biol Chem. 2010; 285:26107-26113.
  文献评价指标  
  下载次数:19次 浏览次数:31次